Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
D000998:Antiviral Agents / Q000494:pharmacology; D001862:Bone Resorption / Q000187:drug effects; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004727:Endothelium / Q000187:drug effects; D006023:Glycoproteins / Q000032:analysis / Q000096:biosynthesis / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D007370:Interferon Type I / Q000096:biosynthesis; D007375:Interleukin-1 / Q000032:analysis / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008934:Mitogens / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000032:analysis; D011971:Receptors, Immunologic / Q000032:analysis; D017472:Receptors, Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha
D000998:Antiviral Agents; D006023:Glycoproteins; D007370:Interferon Type I; D007375:Interleukin-1; D008934:Mitogens; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; D017472:Receptors, Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha